Abstract Objective: Insomnia is the most prevalent sleep disorder, with few effective pharmacotherapies. Anecdotal reports and recent preclinical research suggest…
Abstract Introduction: Sleep disorders are the third most common indication for the prescription of medical cannabis products in Australia, after…
Abstract Background: Δ9-Tetrahydrocannabinol (THC), the main intoxicating component of cannabis, can cause cognitive and psychomotor impairment. Whether this impairment is…
Abstract Global interest in the non‐intoxicating cannabis constituent, cannabidiol (CBD), is increasing with claims of therapeutic effects across a diversity…
Abstract Background: Australia has had a framework for legal medicinal cannabis since 2016, yet prior online surveys in 2016 and…
Abstract Cannabidiol (CBD) is a non-intoxicating cannabinoid derived from Cannabis sativa. CBD initially drew scientific interest due to its anticonvulsant…
Abstract Background: In 2016, the Australian federal government passed legislation enabling a range of cannabis-based products to be prescribed to…
Abstract Introduction: Insomnia is a highly prevalent and costly condition that is associated with increased health risks and healthcare utilisation.…
Abstract Objectives: To examine the knowledge and attitudes of Australian general practitioners (GP) towards medicinal cannabis, including patient demand, GP…